Clarity Science
Clarity Science LLC is a privately held, Narragansett, Rhode Island-based contract research organization that designs and runs IRB-approved clinical outcomes studies for biopharmaceutical companies, specialty pharmacies, and healthcare firms across pain, allergy, sleep, diabetes, and wound-care therapeutic areas.
- Company typePrivate
- Founded2018
- HeadquartersNarragansett, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Clarity Science does
Clarity Science LLC is an international scientific outcomes research company headquartered in Narragansett, Rhode Island, that designs, coordinates, and executes IRB-approved clinical studies for biopharmaceutical companies, specialty pharmacies, and other healthcare organizations. The company operates across therapeutic areas including pain management, allergy immunotherapy, dermatology, diabetes, sleep disorders, cardio-metabolic disease, wound healing, and psychiatry. Its primary offering is professional outcomes-research services — study protocol design, investigator recruitment, real-time electronic data capture, validated data management, and biostatistics — delivered through a network of US-based physician investigators and supported by compliance with GCP, HIPAA, and FWA standards and SOCRA membership. President Peter Hurwitz, with 30+ years in medical communications, leads a small team that has administered 27+ IRB-approved studies since 2012.
The company has built a proprietary data management system with electronic patient informed consent and real-time data capture, and has co-developed an ML-based decision-support product (the Precision Chronic Pain Treatment Tool) with InSyBio that stratifies chronic pain patients across four non-opioid treatment formulations, reporting over 82% predictive accuracy on a cohort exceeding 600 patients. Clarity Science monetizes through B2B professional-services engagements with biopharma and specialty pharmacy sponsors, naming customers including Pain Relief Technologies (Kailo Pain Patch PREVENT trial) and academic collaborators such as the University of Miami Miller School of Medicine. Output is generated both as client deliverables and as peer-reviewed publications and international conference presentations (WIP, SAWC, APWCA, IASP, PAIN Week).
The business model is essentially that of a specialist contract research organization (CRO) focused on late-stage comparative effectiveness and real-world evidence studies, augmented by a single productized AI asset. No external funding, institutional investors, parent company, M&A activity, or pricing transparency are disclosed. The company is privately held, with 1-10 disclosed employees, no app or SDK productization, and a single corporate website (claritysciences.org) serving as both lead-generation and investigator-recruitment channel.
Clarity Science firmographics
Firmographics- Name
- Clarity Science
- Legal name
- Clarity Science LLC
- Website
- https://claritysciences.org
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Clarity Science LLC is a privately held, Narragansett, Rhode Island-based contract research organization that designs and runs IRB-approved clinical outcomes studies for biopharmaceutical companies, specialty pharmacies, and healthcare firms across pain, allergy, sleep, diabetes, and wound-care therapeutic areas.
- Ownership category
- akta.pro rank
Clarity Science industry classification
Industry- Product category
- Clinical Research Services (Contract Research Organization / Outcomes Research)
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
Keywords
Where Clarity Science is headquartered
LocationHeadquarters
- HQ city
- Narragansett
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Clarity Science business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Outcomes Research Services: Clarity Science provides scientific outcomes research services to biopharmaceutical companies, specialty pharmacies, and other healthcare companies. They coordinate and execute IRB-approved clinical studies, assisting with the coordination and execution of scientific, outcomes studies. The company is managed by healthcare professionals, scientific researchers, outcomes statisticians, and guided by physician experts across multiple therapeutic areas.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Clarity Science product offering
Product offeringCore offering
Clarity Science coordinates and executes IRB-approved scientific outcomes research studies for biopharmaceutical companies, specialty pharmacies, and other healthcare organizations across therapeutic areas including pain management, allergy, dermatology, diabetes, cardio-metabolic diseases, sleep disorders, and wound healing. The company also develops machine learning-based predictive tools — including the Precision Chronic Pain Treatment Tool developed with InSyBio — that predict patient response to non-opioid pain treatments with over 82% accuracy. Services include study design, IRB submission, physician investigator network coordination, data capture through a proprietary electronic consent and real-time data management system, statistical analysis, and peer-reviewed publication of results.
Product overview
Clarity Science is an international scientific outcomes research company offering IRB-approved clinical studies and a proprietary machine learning-based tool for predicting chronic pain treatment responses. The company's primary offering consists of clinical research coordination services across multiple therapeutic areas (pain management, allergy, dermatology, diabetes, sleep, cardio-metabolic, mental health, oncology, and wound care), complemented by the Precision Chronic Pain Treatment Tool developed in collaboration with InSyBio for predicting patient response to non-opioid treatments.
Differentiator
Problem solved
Functional benefit
Products and services
- Precision Chronic Pain Treatment Tool A machine learning-based web tool developed in collaboration with InSyBio for predicting chronic pain patient response to non-opioid treatment formulations. It stratifies patients into individuals who will benefit from topical analgesics and selects the most suitable non-opioid treatment formulation, achieving over 82% accuracy in predicting changes in pain severity, interference scales, and reduction of total drugs in a cohort of more than 600 patients.
- Clinical Outcomes Research Studies Services IRB-approved clinical outcomes research studies coordinated and administered in therapeutic areas including pain management, allergy, dermatology, diabetes, cardio-metabolic diseases, sleep disorders, wound healing, psychiatry, and urology. Delivered for biopharmaceutical companies, specialty pharmacies, and other healthcare companies, including study design, IRB submission, investigator network coordination, data capture through a proprietary real-time data management system, statistical analysis, and dissemination in peer-reviewed journals.
Quantifiable outcome
- 71% decrease in BPI Severity score (5.2 to 1.5/10; p< .001)
- +5 more outcomes
Companies that use Clarity Science
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Clarity Science technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
Clarity Science partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- InSyBiocoreInSyBio collaborated with Clarity Science to develop a machine learning-based tool for predicting chronic pain patient response to non-opioid treatments. The Precision Chronic Pain Treatment Tool capitalizes on InSyBio's machine learning technology to predict treatment response metrics with over 82% accuracy in a cohort of more than 600 patients. This first-of-its-kind tool stratifies chronic pain patients and suggests suitable non-opioid treatment formulations.
- Pain Relief TechnologiescorePain Relief Technologies (Sandy, Utah) partnered with Clarity Science for the PREVENT clinical trial evaluating the Kailo Pain Patch nanotechnology-based non-drug pain patch. The study showed significant pain relief outcomes with 71% decrease in pain severity and no side effects reported.
- University of Miami, Miller School of MedicinecoreDr. Jeffrey Gudin, affiliated with University of Miami Miller School of Medicine Department of Anesthesiology and Pain Management, served as Principal Investigator for the PREVENT Study. Dr. Gudin is board certified in pain management, anesthesiology, addiction medicine and palliative care and is an opinion leader in pain management.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Clarity Science competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Biopharma solutions organization combining CRO services with commercial and real-world evidence offerings. Overlaps with Clarity Science's outcomes research and investigator network capabilities.
- IQVIA: Largest global CRO and real-world evidence provider, offering end-to-end clinical research and outcomes services. Competes for the same biopharma outcomes research budgets but at far greater scale and breadth than Clarity Science.
- ICON plc: Global CRO providing clinical research, biometrics, and real-world evidence services to biopharma. Overlaps with Clarity Science's outcomes research offerings as part of a much wider portfolio.
- Charles River Laboratories: Established life sciences research organization spanning discovery, safety, and clinical support. Comparable in providing scientific research services to biopharma, though at far broader scope than Clarity Science.
Direct peers
- Medpace: Mid-size, clinically-focused CRO running multi-therapeutic global trials for biopharma sponsors. Directly comparable as a contract research organization competing for the same biopharma and specialty pharma outcomes research budgets as Clarity Science.
- Premier Research: Specialty CRO focused on pain, CNS, oncology, and rare disease clinical research. Comparable business model of delivering therapeutic-focused outcomes studies to biopharma, similar in scope and positioning to Clarity Science.
- Worldwide Clinical Trials: Mid-tier global CRO with strong pain, neuroscience, and specialty therapeutic expertise. Comparable as a mid-sized specialty outcomes research organization targeting biopharma clients similar to Clarity Science's customer base.
Emerging players
- Veeva Systems: Clinical trial and life sciences software vendor whose EDC, CTMS, and ePRO platforms underpin modern trial data collection. Adjacent peer reflecting the technology backbone Clarity Science's proprietary data management system competes against.
- Medidata Solutions: Dassault Systèmes-owned clinical trial technology platform offering EDC, eCOA, and AI-driven analytics. Comparable as a technology-led player in clinical trial informatics, relevant to Clarity Science's data management and ML analytics positioning.
- Clario: Clinical trial technology and eCOA/ePRO provider formed from ERT and Bioclinica. Comparable as a specialist in patient-facing clinical data collection and digital endpoints, directly relevant to Clarity Science's outcomes data capture focus.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat4 records
Key risks1 record
Key highlights7 records
Customer concentration
Clarity Science social profiles
Digital presenceClarity Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clarity Science leadership team
Management profileNumber of profiles
Profiles1 record
Clarity Science funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clarity Science M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clarity Science
What does Clarity Science do?
Clarity Science coordinates and executes IRB-approved scientific outcomes research studies for biopharmaceutical companies, specialty pharmacies, and other healthcare organizations across therapeutic areas including pain management, allergy, dermatology, diabetes, cardio-metabolic diseases, sleep disorders, and wound healing. The company also develops machine learning-based predictive tools — including the Precision Chronic Pain Treatment Tool developed with InSyBio — that predict patient response to non-opioid pain treatments with over 82% accuracy. Services include study design, IRB submission, physician investigator network coordination, data capture through a proprietary electronic consent and real-time data management system, statistical analysis, and peer-reviewed publication of results.
Is Clarity Science a public or private company?
Clarity Science is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Clarity Science founded?
Clarity Science was founded in 2018. It employs 1 to 10 people.
Where is Clarity Science based?
Clarity Science is headquartered in Narragansett, United States, in the North America region.
How does Clarity Science make money?
One revenue line is on record: outcomes Research Services.
Who are Clarity Science's main competitors?
Broad incumbents on record are Syneos Health, IQVIA, ICON plc and Charles River Laboratories. Direct peers are Medpace, Premier Research and Worldwide Clinical Trials. Emerging players are Veeva Systems, Medidata Solutions and Clario.
Does Clarity Science have an API?
No public API is recorded for Clarity Science.
What industry is Clarity Science in?
Clarity Science's product category is Clinical Research Services (Contract Research Organization / Outcomes Research). Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its NAICS code is 5417 and its SIC code is 8731.